Article Name Medical Diagnostic

Scopio Labs secures $42 million in funding led by Fortissimo Capital

To accelerate Scopio Labs' commercial growth and product innovation in full-field digital cell morphology...Read more

25th July, 2024


Japan-based Fujifilm expands health screening service business in Mongolia

New NURA health screening centre opens in Ulaanbaatar...Read more

24th July, 2024


BD and Quest Diagnostics collaborate to develop companion diagnostics for cancer

To provide an end-to-end solution for CDx development...Read more

25th July, 2024


Thyrocare acquires Polo Labs' Pathology diagnostic business to strengthen northern India presence

Polo Labs serves a substantial client base and has a significant market presence in Northern India, contributing to the region's healthcare infrastructure...Read more

25th July, 2024


Paige demonstrates first clinical-grade performance for cancer detection using a foundation model ‘Virchow’

Paige’s collaboration with Microsoft in AI-driven technology for propelling cancer diagnosis forward...Read more

23rd July, 2024


EMVision unveils backpack-sized brain scanner to empower first responders

Miniaturising its portable brain scanner technology to tackle the global burden of stroke ...Read more

22nd July, 2024


First nationwide adoption of AI in national-level breast screening workflow in Middle East

Lunit's AI solution enhances Qatar's national breast cancer screening programme...Read more

22nd July, 2024


VitalLife and Bumrungrad in Thailand launch NEC's FonesVisuas test, revolutionizing disease risk prediction outside Japan

VitalLife has pioneered personalized healthcare solutions by integrating cutting-edge research and technology...Read more

18th July, 2024 | By Vrushti Kothari 


Mankind Pharma signs non-exclusive patent license agreement with Takeda to commercialize Vonoprazan in India

Mankind Pharma and Takeda Pharmaceutical Ink Licensing Deal to Launch Novel GERD Treatment in India...Read more

16th July, 2024 | By Vrushti Kothari 


Mankind Pharma signs non-exclusive patent license agreement with Takeda to commercialize Vonoprazan in India

Mankind Pharma and Takeda Pharmaceutical Ink Licensing Deal to Launch Novel GERD Treatment in India...Read more

16th July, 2024 | By Vrushti Kothari 


© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer